Found 14 matching trials
IL-1ra Dose-range Study for Moderate-to-severe TBI Patients PHASE2 Traumatic brain injury (TBI) is a common condition with high degree of morb...
Show More Location
Cambridge University Hospital NHS Trust
Learn More & Join Trial
Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) PHASE2 Phase 2/3 randomized, parallel group, 2-arm study (treatment vs. control), ...
Show More Location
Hospital Universitario Miguel Servet
Learn More & Join Trial
Anti-Cytokine Therapy for Hemodialysis InflammatION PHASE2 Anti-Cytokine Therapy for Hemodialysis InflammatION (ACTION) is a phase II ...
Show More Location
The George Washington University
Learn More & Join Trial
Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever PHASE3 FMF is the most common periodic fever with a worldwide patient population e...
Show More Location
Sheba Medical Center
Learn More & Join Trial
Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients PHASE1 The ACO/ARO/AIO-21 investigator-driven, open-labeled, phase I drug re-purpo...
Show More Location
University Hospital Goethe University Frankfurt
Learn More & Join Trial
SCIL-1Ra in COVID-19 Feasibility & PK/PD PHASE2 The current COVID-19 pandemic is a worldwide healthcare crisis. Of concern ...
Show More Location
Manchester Univesity NHS Foundation Trust
Learn More & Join Trial
BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage PHASE2 This trial will help inform the development of a new treatment for intracer...
Show More Location
Salford Royal NHS Foundation Trust
Learn More & Join Trial
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia PHASE2 The current study is an exploratory, phase IIa randomized clinical trial (R...
Show More Location
4th Department of Internal Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Medical School
Learn More & Join Trial
A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study PHASE2 The study is designed as a randomized, controlled, multi-center open-label ...
Show More Location
Karolinska University Hospital
Learn More & Join Trial
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome PHASE2 The PRECISION is a proof-of-concept, phase II randomized clinical trial aim...
Show More Location
Out-patient long-COVID department, Jena University Hospital
Learn More & Join Trial